Citations

Clear

7 citation(s) found for "Hossain, Nadia".

TDP-43 Coincides with Noradrenergic Neurons in Alzheimer’s Disease (AD) and Primary Age-Related Tauopathy (PART)
Youseff, Hossam , Whitwell, Jennifer L , Hossain, Nadia , Bhaskaran, Jerusha , Machulda, Mary M , Whitwell, Jennifer , Reichard, Robert Ross, Josephs, Keith A

Mayo Clinic

Cells | October 12, 2026 | Volume: 15 | Issue: 20 | Pages: 1850

10.3390/cells15201850 | PMID 42929824 Get It

TAR DNA-binding protein 43 (TDP-43) pathology is a major contributor to cognitive decline in Alzheimer’s disease (AD), yet the cellular substrates and circuit-level consequences of its limbic accumulation remain poorly defined. Here, we combined multiplex immunofluorescence with 3D Artificial Intelligence (AI)-based object detection and quantitative colocalization to map phosphorylated TDP-43 (pTDP-43) across neuronal subtypes in the amygdala, hippocampal subfields, and entorhinal cortex (ERC) in human AD, AD with Lewy body disease (AD-LBD), and primary age-related tauopathy (PART). Across 15 deeply phenotyped cases, pTDP-43 showed preferential accumulation in neuromodulatory noradrenergic neurons, with more limited involvement of glutamatergic terminals and cholinergic populations. Noradrenergic neurons marked by dopamine β-hydroxylase (DβH) demonstrated extensive colocalization with pTDP-43 across regions, correlating with APOE genotype, amyloid burden, and tau staging in this cross-sectional cohort, suggesting that neuromodulatory circuits might represent a major convergence point for AD-related molecular stressors. Dopaminergic (tyrosine hydroxylase (TH)) and cholinergic (choline acetyltransferase (ChAT)) neurons showed more restricted but pathology-dependent involvement, with LBD consistently showing lower pTDP-43 burden across multiple transmitter systems. Glutamatergic vesicular glutamate transporter-1 (VGLUT1)-positive neurons and terminals exhibited minimal colocalization except in PART. Principal component (PCA) and hierarchical clustering analyses (HCA) integrating pTDP-43 colocalization with neuropathologic staging metrics (A, B, C, Thal, Braak, LBD) reliably separated PART, AD-TDP, and AD-TDP-LBD groups, with LBD emerging as a dominant modifier of cellular vulnerability. Together, these findings point out that TDP-43 pathology in AD preferentially targets neuromodulatory circuits, is strongly shaped by coexisting synucleinopathy, and provides a cell-type-resolved framework for understanding how TDP-43 contributes to limbic network dysfunction in neurodegeneration.
Structural Heterogeneity of TDP‐43 Fragments in Alzheimer's Disease and Primary Age‐Related Tauopathy by Artificial Intelligence (AI)–Based 3D Segmentation
Uruk, Gӧkhan , Gatto, Rodolfo G. , Hossain, Nadia , Whitwell, Jennifer L. , Reichard, R. Ross, Josephs, Keith A. , Uruk, Gokhan , Whitwell, Jennifer L , Reichard, R. Ross

Mayo Clinic

Neuropathology and Applied Neurobiology | August 11, 2026 | Volume: 52 | Issue: 4 | Pages: No page available

10.1111/nan.70096 | PMID 42576167 Get It

ABSTRACT TAR DNA‐binding protein 43 (TDP‐43) inclusions are defining pathological features of frontotemporal lobar degeneration (FTLD) but are also often observed in Alzheimer's disease ( AD ) and primary age‐related tauopathy (PART). TDP‐43 in AD is either associated with cognitive impairment or a protective‐life prolonging impact, and yet the localization, cellular and fragment characteristics of TDP‐43 need to be determined. We investigated the relationships between TDP‐43 volumetric inclusion burden in low likelihood AD (lAD) and definite PART by immunostaining against phosphorylated TDP‐43 (pTDP‐43), TDP‐43 C terminal (TDP‐C) and TDP‐43 N‐terminal (TDP‐N) fragments combined with 3D confocal imaging taken from eight regions: amygdala (basolateral [amygdala‐BL] and centromedial amygdala [amygdala‐CM]), the hippocampus (Cornu Ammonis [CA]‐1, CA2/3, CA4, dentate gyrus [DG] and subiculum [SUB]) and entorhinal cortex (ERC) and artificial intelligence (AI)–based segmentation via object recognition, reconstruction and quantification. We found amygdala‐CM in lAD and PART to have the overall greatest burden of pTDP‐43 whereas TDP‐N burden in amygdala‐BL of PART cases was greater than other TDP‐43 fragments. There was no difference in TDP‐43 burden in hippocampal subfields in PART. However, CA2/3 region showed greater pTDP‐43 burden while TDP‐N stood out in DG and SUB. Multiple comparisons among the groups revealed that TDP‐C was the only fragment showing differences among PART and lAD in CA2/3, DG and SUB regions. Overall, unbiased AI‐based volumetric burden analysis pipeline demonstrated unique fragment aggregation patterns in the neurodegenerative processes of PART and AD .
Artificial intelligence–based 3D segmentation of tangle‐associated TDP ‐43 in neurodegeneration
Uruk, Gӧkhan , Gatto, Rodolfo G. , Hossain, Nadia , Whitwell, Jennifer L. , Reichard, Robert R., Josephs, Keith A. , Uruk, Gokhan , Youseff, Hossam , Whitwell, Jennifer L , Hossain, Nadia , Whitwell, Jennifer , Josephs, Keith A , Youssef, Hossam , Reichard, R. Ross

Mayo Clinic

Brain Pathology | August 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/bpa.70131 | PMID 42568211 Get It

Abstract TAR DNA‐binding protein 43 (TDP‐43) inclusions are often associated with hyperphosphorylated tau, thus neurofibrillary tangles as the hallmark of Alzheimer's disease (AD) and primary age‐related tauopathy (PART). TDP‐43 in AD is associated with cognitive impairment, and while staging is known, the localization, cellular and inclusion characteristics of TDP‐43 are yet to be elucidated. We investigate relationships between TDP‐43 inclusions and the tangle maturation continuum in AD, PART, and co‐pathologies by multiplex immunostaining combined with artificial intelligence (AI)–based segmentation via object recognition, reconstruction, and quantification. We performed anti‐phosphorylated TDP‐43 immunofluorescence with phosphorylated tau labeling different stages and modifications of tangles (AT8, pS396, TauC3, MN423, GT38) in three controls, three cases with PART and TDP‐43 (PART‐TDP), five cases with high likelihood AD and TDP‐43 (AD‐TDP), and four cases of high likelihood AD with TDP‐43 and Lewy Body disease (AD‐TDP‐LBD). Confocal imaging was taken from eight regions: amygdala (amygdala‐BL and amygdala‐CM) and hippocampus (Cornu Ammonis (CA)‐1, CA2/3, CA4, dentate gyrus (DG), subiculum (SUB)), and entorhinal cortex (ERC) and quantified with AI segmentation to identify 3D spatial relations, thus the maturity of neurofibrillary tangle associated TDP‐43 (TAT) inclusions. TATs, which were either identified by pTDP‐43 and AT8 or pTDP‐43 and pS396 double positivity, were also investigated by Thioflavin S (ThioS) histochemistry. We found pS396 labeled mature TATs predominated in PART and AD in every region. Basolateral and centromedial amygdala displayed overall greatest number of pre‐TATs and mature TATs. Mature TATs were homogenously distributed among hippocampal subfields whereas CA4 and DG had the greatest mature TAT composition. ERC revealed closer numbers of pre‐TATs and mature TATs yet mature TATs predominated all groups. Unbiased AI‐based object identification, reconstruction, and TAT maturation analysis pipeline in conjunction with TDP‐43, tau, and ThioS multiplex immunostaining demonstrated unique aggregation and maturation patterns, highlighting region‐specific dynamics in the neurodegenerative processes of PART and AD.
Anatomical and Clinical Characteristics of Behavioral Variant Frontotemporal Dementia with Progressive Apraxia of Speech (P8-12.011)
Hossain, Nadia, Bhaskaran, Jerusha, Duffy, Joseph, Clark, Heather, Machulda, Mary, Dickson, Dennis, Whitwell, Jennifer , Josephs, Keith, Bhaskaran, J., Duffy, Joseph, Clark, Heather M. , Machulda, Mary M.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000212917 Get It

Behavioral Variant Frontotemporal Dementia in the Context of Progressive Apraxia of Speech: A Clinico-Neuroimaging Case–Control Study
Hossain, Nadia , Bhaskaran, Jerusha, Duffy, Joseph R. , Clark, Heather M. , Whitwell, Jennifer L., Josephs, Keith A. , Josephs, Keith A , Clark, Heather M , Duffy, Joseph R , Hossain, Nadia , Bhaskaran, Jerusha, Machulda, Mary M. , Dickson, Dennis W. , Whitwell, Jennifer

Mayo Clinic

Brain Sciences | October 31, 2025 | Volume: 15 | Issue: 11 | Pages: 1169

10.3390/brainsci15111169 | PMID 41300176 Get It

Objective: Progressive apraxia of speech (PAOS) is a neurodegenerative syndrome characterized by impaired motor speech planning and programming, whereas behavioral variant frontotemporal dementia (bvFTD) is characterized by deviant behavioral (e.g., personality and social) features. Clinical and anatomic characteristics of bvFTD in the context of PAOS are understudied. Methods: We identified 12 participants with PAOS and features that were consistent with bvFTD at baseline or follow-up. Eleven completed a head MRI scan. We compared clinical features and anatomical patterns of atrophy in these 11 PAOS-bvFTD participants to 11 matched PAOS participants without bvFTD and 22 age- and sex-matched healthy controls. Statistical Parametric Mapping (SPM) was applied to visualize gray matter volume across both groups compared to controls and each other. Medians and 25th and 75th percentiles were assessed in patients and across groups; Fisher’s Exact Test and Mann–Whitney U tests were applied using BlueSky software, version 10.3.1-Pro. Results: As expected, PAOS-bvFTD participants performed worse on the Frontal Behavioral Inventory (median: 33/72 vs. 10/72), 20-item behavioral assessment scale (4.5/20 vs. 1.0/20), and the Neuropsychiatry inventory (4/36 vs. 1.5/36) compared to the PAOS group (p < 0.01 for all), with no differences in other demographic, neurological, or language tests. Seven of the eleven PAOS-bvFTD participants had bvFTD features develop within three years of symptom onset. The PAOS-bvFTD and PAOS groups showed volume loss in frontal lobe regions compared to controls, with PAOS-bvFTD participants having more prefrontal volume loss than PAOS participants. Conclusions: Behavioral features consistent with bvFTD can co-occur in patients with PAOS and are related to greater atrophy of the prefrontal cortex.
Clinicopathological and Neuroimaging Correlates of Disease Duration in Primary Progressive Apraxia of Speech
Hossain, Nadia , Bhaskaran, Jerusha, Ross, Owen A. , Whitwell, Jennifer L. , Josephs, Keith A. , Ross, Owen A , Hossain, Nadia, Clark, Heather M. , Duffy, Joseph R. , Machulda, Mary M. , Lavrova, Anna , Bhaskaran, Jerusha, Dickson, Dennis W. , Whitwell, Jennifer L.

Mayo Clinic

European Journal of Neurology | September 25, 2025 | Volume: 32 | Issue: 9 | Pages: No page available

10.1111/ene.70366 | PMID 40993958 Get It

ABSTRACTBackgroundPrimary progressive apraxia of speech is a neurodegenerative disorder characterized by early, isolated speech impairment due to impairment of motor speech planning and programming. Patients with PPAOS have varying disease durations from the estimated onset of the first symptom to death. Clinicopathological and neuroimaging features related to disease duration are unknown for PPAOS. We determine whether clinical, neuroimaging, or pathological features are associated with disease duration in primary progressive apraxia of speech (PPAOS).MethodsWe analyzed data from 41 PPAOS participants who were enrolled and longitudinally followed to death in NIH‐funded studies over 15 years. Demographic, clinical, and genetic features were abstracted. Brain volumes of cortical, subcortical, and brainstem regions were calculated. Regional tau lesion count (burden) was assessed histologically. Spearman rank correlations were performed between disease duration and variables of interest, followed by multiple regression analyses.ResultsDisease duration did not correlate with any baseline demographic, clinical, or pathologic features. Shorter disease duration correlated with a faster rate of behavioral change and of apraxia of speech severity over time, smaller baseline volumes of the superior frontal lobe and supplementary motor cortex, and higher tau burden in the locus ceruleus (ρ = −0.5, p = 0.03). Multiple regression analysis identified rate of behavioral change and volume loss in the superior frontal lobe as key clinical and neuroimaging variables, respectively.ConclusionIn patients with PPAOS, we found shorter disease duration to be related to behavioral dyscontrol and involvement of the frontal lobe, as well as a higher burden of 4‐repeat tau lesions in the locus ceruleus.
Long Disease Duration Primary Progressive Apraxia of Speech: A Clinicopathological Study (P2-3.001)
Hossain, Nadia , Utianski, Rene, Duffy, Joseph, Whitwell, Jennifer , Josephs, Keith A. , Hossain, Nadia, Meade, Gabriela , Clark, Heather, Machulda, Mary M. , Lavrova, Anna , Dickson, Dennis W. , Botha, Hugo

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210535 Get It